2015
$120M
from 8 investors over 8 rounds
EpimAb Biotherapeutics, Inc. raised $120M on March 22, 2021
Investors: Octagon Capital Advisors, Hony Capital, Decheng Capital, 夏尔巴股权投资管理有限公司 and ShangBay Capital
EpimAb Biotherapeutics, Inc. raised $74M on June 5, 2019
Investors: 夏尔巴股权投资管理有限公司
EpimAb Biotherapeutics, Inc. raised $25M on April 24, 2017
Investors: Decheng Capital and 3E Bioventures Capital